PIK3CA and head and neck squamous cell carcinoma: As HER3 is not expressed in T cells, this provided a unique opportunity to disable PI3K/mTOR oncogenic signaling in HNSCC while bypassing the immunosuppressive effects of small molecule inhibitors of downstream targets in this signaling axis.